Cargando…
When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromycin, ciproflo...
Autores principales: | Bibi, Mário, Ferro, Ana, Guimarães, Filipa, Coelho, Paulo, Chora, Inês |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276924/ https://www.ncbi.nlm.nih.gov/pubmed/34268273 http://dx.doi.org/10.12890/2021_002661 |
Ejemplares similares
-
To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery?
por: van Duren, Bernard H, et al.
Publicado: (2021) -
When it starts in the skin and goes to the lungs, where does it stop?
por: Catarino Ferro, Ana Rita, et al.
Publicado: (2022) -
P02 When should we stop the antiresorptive medications in patients with osteoporosis?
por: Mohareb, Marwa, et al.
Publicado: (2023) -
Evaluation of pulmonary function in post-COVID-19 patients - when and how should we do it?
por: Fonseca, Ana, et al.
Publicado: (2021) -
Acute on chronic heart failure—Which variations on B‐type natriuretic peptide levels?
por: Bettencourt, Paulo, et al.
Publicado: (2021)